comparemela.com

Latest Breaking News On - Mark ebell - Page 1 : comparemela.com

Are benefits of the new Alzheimer s drug overblown?

The cost, time burden, and potential side effects of a new Alzheimer's drug may not be worth the minimal benefit, research suggests.

Study questions benefit of new Alzheimer s drug

Alzheimer s: The risks of monoclonal antibodies may outweigh benefits

Researchers are reporting that the risks from monoclonal antibody treatments for Alzheimer's appear to outweigh the benefits, so these therapies probably people shouldn't be used on most people with the disease

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.